Drug & intervention

atrasentan

RxCUI 2710449

Clinical trials10
Recruiting0
Related conditions14
Synonyms1

RxNorm ingredient and formulation relationships

Source-verified product relationships. Every strength, delivery form and RxCUI remains a separate clinical concept.

Loading RxNorm relationships…

Clinical trials

10 shown
Atrasentan in Patients With Proteinuric Glomerular DiseasesNCT04573920 · 2021-03-15
ACTIVE_NOT_RECRUITING
Atrasentan Spermatogenesis and Testicular FunctionNCT02118714 · 2015-04-06
COMPLETED
Study Of Diabetic Nephropathy With AtrasentanNCT01858532 · 2013-05-17
TERMINATED
A Prospective, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate Efficacy and Safety of Atrasentan, Including Thoracic Bioimpedance, in Type 2 Diabetic Subjects With NephropathyNCT01399580 · 2011-08-01
COMPLETED
Evaluate the Efficacy and Safety of Once Daily Administration of Atrasentan Tablets (Low and High) Compared to Placebo in Reducing Residual Albuminuria in Type 2 Diabetic Patients With Nephropathy Who Are Treated With the Maximum Tolerated Labeled Dose of a Renin Angiotensin System (RAS) InhibitorNCT01356849 · 2011-04-01
COMPLETED
Safety and Efficacy of Atrasentan in Men With Hormone Naive Prostate Cancer Exhibiting Early Signs of Biochemical FailureNCT00038662 · 2002-05-01
COMPLETED
Atrasentan and Zometa for Men With Prostate Cancer Metastatic to BoneNCT00181558 · 2001-12-01
COMPLETED
A Long Term Safety Study With AtrasentanNCT00127478 · 2001-07-01
COMPLETED
Study of Atrasentan in Men With Non-Metastatic, Hormone-Refractory Prostate CancerNCT00036556 · 2001-06-01
COMPLETED
A Study of Atrasentan in Men With Metastatic, Hormone-Refractory Prostate CancerNCT00036543 · 2001-05-01
COMPLETED

Drug identity and terminology: RxNorm. Trial relationships: ClinicalTrials.gov.